Blog
Revolutionizing Biomanufacturing: Unlocking the Power of Smart Technology
π¬πβ¨ The digital revolution in biomanufacturing is here! Discover the challenges and success stories of industry leaders. πππ
Supercharge Vaccine Development with Automation and Collaboration
π§ͺ Recombinant protein vaccines are safe, effective, and easy to store, making them a leading human vaccine technology. β° Shortening the time from vaccine discovery to commercialization is crucial for better pandemic preparedness. π€ Automation and digitalization can speed up vaccine development. π₯ Collaboration and open access platforms can facilitate knowledge sharing and ensure global access to vaccines. πͺ Scalable biotech manufacturing facilities with modular and flexible technologies are essential for large-scale production. π CDMOs have become crucial in responding to vaccine production demands. π Ensuring stable supply chains and timely regulatory certifications is necessary for CDMOs.
Moderna’s $900m Investment for Global Biotech Growth
π° Moderna plans to invest $900m in capital expenditures in 2024 to support growth ambitions in biotechnology. π¬πβοΈπ
Finnish Company Receives β¬12m Grant to Revolutionize Protein Production
π’ Finnish Enifer Oy receives β¬12m grant to build a mycoprotein factory, aiming for sustainable protein production π. FinnishInnovation
Pharma’s Tech Revolution: AI and Synbio Supercharge Biologics
π° Pharma is using new technologies like AI and synthetic biology to maximize biologics manufacturing. π Innovations are improving antibody stability and yield, accelerating production and drug development. π
Revolutionary System Boosts Lentiviral Vector Production
π Scaling-up production of lentiviral vectors (LV)-based therapies is a challenge for biomanufacturers. ππ¬ McGill University researchers have developed a semi-continuous manufacturing system that enhances the quantity and recovery of LVs, reduces instability, and cuts processing time by four-fold. β±οΈπͺ The system integrates upstream and downstream bioprocesses, resulting in significant time savings. π‘β¨ It operates by rotating membranes between two systems, improving efficiency. ππ
Boost Efficiency and Speed with AI Automation
π€ Automation in process development can improve efficiency and speed up the optimization of processes. Currently, automation is not widely used in the process development lab, but it has been successful in drug discovery and production plants. π¬ Automation combined with digitalization can provide better data management and insights into bioprocesses. π₯ Collaboration with technology suppliers and a solid data infrastructure are essential for successful automation projects. π€ Challenges include the lack of regulatory standards for the development and deployment of AI in medical use cases. π¨βπ¬ AI has potential applications in process development, such as cell therapy manufacturing and production scheduling. π AI is already used to process lab images and make process decisions. π‘ Automation and AI can greatly benefit process development and lead to more efficient drug manufacturing.
Breakthrough: New Cell Type for Better AAV-Based Drugs!
π¬ Researchers are searching for the perfect cell type to produce rAAVs for gene therapies. π§ͺ HEK293 and CHO cells are being considered. πΉπ‘π
Mogu Srl Secures β¬11m to Revolutionize Mycelium Technology
π’ Italian mycelium specialist Mogu Srl raises β¬11m to scale technology, accelerate industrial scaling, and boost R&D efforts. π°π
2024: The Year of Breakthroughs in Bioprocessing?
Will 2024 be the year of breakthroughs in bioprocessing? π Find out in this insightful article! Bioprocessing2024
